NewGenIVF Group shares surge 12.37% premarket after announcing 1-for-3 reverse stock split and appointing Web3 leader Joshua Chu.
ByAinvest
Monday, Jan 26, 2026 9:16 am ET1min read
NIVF--
NewGenIVF Group surged 12.37% in premarket trading following the announcement that its board approved a one-for-three reverse stock split on December 23, 2025. The move, applicable to all share classes and not requiring shareholder approval, signals the company’s strategic effort to enhance share value and potentially improve liquidity. The reverse split is expected to consolidate the company’s capital structure, a development often viewed favorably by investors as it may indicate improved financial positioning or compliance with exchange requirements. While the split implementation date remains in the future, the approval itself has driven immediate optimism in the premarket session.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet